A Phase 2, Multiple-Dose, Pharmacokinetic and Pharmacodynamic Study of RDEA594 in Gout Patients with Hyperuricemia and Gout with Renal Insufficiency

Trial Profile

A Phase 2, Multiple-Dose, Pharmacokinetic and Pharmacodynamic Study of RDEA594 in Gout Patients with Hyperuricemia and Gout with Renal Insufficiency

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Aug 2012

At a glance

  • Drugs Lesinurad (Primary) ; Allopurinol; Oxipurinol
  • Indications Gout
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Aug 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 16 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top